Use of atypical antipsychotics in mood disorders

R. Weizman, A. Weizman*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review


Cumulative data indicate that atypical antipsychotics can serve as adjunctive as well as alternative agents in the treatment of drug-resistant mood disorders. Olanzapine and risperidone add-on treatment was found to be effective for major depression with psychotic features and good results were achieved with currently available atypical antipsychotics (clozapine, risperidone, olanzapine, quetiapine and ziprasidone) in reducing symptoms of acute mania, especially when added to mood stabilizers. The role of atypical antipsychotics in maintenance and prophylactic treatment is not yet clear. Although there are differences in the side effect profiles of the various atypical antipsychotics, their use is limited by adverse effects such as extrapyramidal symptoms, weight gain, somnolence and sexual dysfunction.

Original languageEnglish
Pages (from-to)940-945
Number of pages6
JournalCurrent Opinion in Investigational Drugs
Issue number7
StatePublished - 2001


  • Atypical antipsychotics
  • Bipolar disorder
  • Clozapine
  • Depression
  • Mood disorders
  • Olanzapine
  • Quetiapine
  • Risperidone
  • Schizoaffective disorder
  • Schizophrenia
  • Ziprasidone


Dive into the research topics of 'Use of atypical antipsychotics in mood disorders'. Together they form a unique fingerprint.

Cite this